Hiroyuki Iwano

Hiroyuki Iwano

Auto-generated profile, based on publicly available information

Hiroyuki Iwano

Division of Cardiology, Teine Keijinkai Hospital, Sapporo, Japan

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2021 in Journal of the American Society of Echocardiography
Verified
Journal Article
Open access
MMMichito Murayama
Michito Murayama
HIHiroyuki Iwano
Hiroyuki Iwano
HNHisao Nishino
Hisao Nishino
STShingo Tsujinaga
Shingo Tsujinaga
MNMasahiro Nakabachi
Masahiro Nakabachi
TAToshihisa Anzai
Toshihisa Anzai
When left ventricular (LV) filling pressure (FP) increases, the mitral valve (MV) opens early and precedes tricuspid valve (TV) opening in early diastole. We hypothesized that a visually-assessed time sequence of atrioventricular valves opening could become a new marker of elevated LVFP. We thus tested the diagnostic ability of a novel echocardiographic scoring system, visually-assessed time-difference between MV and TV opening (VMT) score, in heart failure (HF) patients. We retrospectively analyzed 119 consecutive patients who underwent cardiac catheterization within 24 hours of echocardiography examination as a derivation cohort. In addition, a prospective study was conducted to validate the diagnostic ability of the VMT score in 50 patients. Elevated LVFP was defined as mean pulmonary arterial wedge pressure (PAWP) ≥15 mmHg. Time sequence of atrioventricular valves opening was visually assessed and scored (0, TV first; 1, simultaneous; 2, MV first). When the inferior vena cava was dilated, 1 point was added and VMT score was finally graded as 0-3. Cardiac events were recorded for 1 year after echocardiography. In the derivation cohort, PAWP was elevated in the higher VMT scores (0, 10±5; 1, 12±4; 2, 22±8; 3, 28±4 mmHg; ANOVA P<0.001). VMT≥2 predicted elevated PAWP with an accuracy of 86% and showed an incremental predictive value over clinical variables and guideline-recommended diastolic function grading. These observations were confirmed in the prospective validation cohort. Importantly, VMT≥2 discriminated elevated PAWP with accuracy of 82% in 33 patients with monophasic LV inflow in the derivation cohort. Kaplan-Meier analysis demonstrated that patients with VMT≥2 were at a higher risk of cardiac events than those with VMT≤1 (P<0.001). VMT scoring could be a novel additive marker of elevated LVFP and might also be associated with adverse outcomes in HF patients.

1 March 2020 in The American Journal of Cardiology
Verified
Journal Article
Closed access
YKYuta Kobayashi
Yuta Kobayashi
KOKazunori Omote
Kazunori Omote
TNToshiyuki Nagai
Toshiyuki Nagai
KKKiwamu Kamiya
Kiwamu Kamiya
TKTakao Konishi
Takao Konishi
TAToshihisa Anzai
Toshihisa Anzai

1 September 2019 in Internal Medicine
Verified
Journal Article
Open access
PDF file
YTYumi Takahashi
Yumi Takahashi
HIHiroyuki Iwano
Hiroyuki Iwano
INIppei Nakano
Ippei Nakano
AFArata Fukushima
Arata Fukushima
MNMasanao Naya
Masanao Naya
TAToshihisa Anzai
Toshihisa Anzai
Although cardiac involvement is rare in polyneuropathy, organomegaly, endocrinopathy, M protein, and skin changes (POEMS) syndrome, the clinical course becomes considerably worse on complication with cardiac lesions. The increased release of various cytokines has been observed in the pathogenesis of POEMS syndrome, and serum vascular endothelial growth factor (VEGF) levels are known to be associated with the disease activity. We herein report a patient with POEMS syndrome who showed left ventricular systolic dysfunction and was treated with lenalidmide therapy. Of note, the reduction in extracellular edema in the left ventricular wall was clearly visualized by changes in the native T1 values and extracellular volumes on cardiac magnetic resonance imaging.

7 November 2020 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
THTomonari Harada
Tomonari Harada
MOMasaru Obokata
Masaru Obokata
KOKazunori Omote
Kazunori Omote
HIHiroyuki Iwano
Hiroyuki Iwano
TITakahiro Ikoma
Takahiro Ikoma
MKMasahiko Kurabayashi
Masahiko Kurabayashi
This study sought to determine the independent and incremental prognostic value of semiquantitative measures of tricuspid regurgitation (TR) severity over right heart remodelling and pulmonary hypertension (PH) in heart failure with preserved ejection fraction (HFpEF). Echocardiography was performed on 311 HFpEF patients. TR severity was defined by the semiquantitative measures [i.e. vena contracta width (VCW) and jet area] and by the guideline-based integrated qualitative approach (absent, mild, moderate, or severe). All-cause mortality or heart failure hospitalization occurred in 101 patients over a 2.1-year median follow-up. There was a continuous association between TR severity and the composite outcome with a hazard ratio (HR) of 1.17 per 1 mm increase of VCW [95% confidence interval (CI) 1.08–1.26, P < 0.0001]. Compared with patients with the lowest VCW category (≤1 mm), RV-adjusted HRs for the outcome were 1.99 (95% CI 1.05–3.77), 2.63 (95% CI 1.16–5.95), and 5.00 (95% CI 1.60–15.7) for 1–3, 3–7, and ≥7 mm VCW categories, respectively. TR severity as defined by the guideline-based approach showed a similarly graded association, but it was no longer significant in models including PH. In contrast, VCW remained independently and incrementally associated with the outcome after adjusting for established prognostic factors, as well as RV diameter and PH (fully adjusted HR 1.14 per 1 mm, 95% CI 1.02–1.27, P = 0.02; χ2 58.8 vs. 51.5, P = 0.03). The current data highlight the potential value of the semiquantitative measures of TR severity for the risk stratification in patients with HFpEF.

25 October 2021 in European Heart Journal - Cardiovascular Imaging
Verified
Journal Article
Open access
PDF file
MMMichito Murayama
Michito Murayama
HIHiroyuki Iwano
Hiroyuki Iwano
MOMasaru Obokata
Masaru Obokata
THTomonari Harada
Tomonari Harada
KOKazunori Omote
Kazunori Omote
TAToshihisa Anzai
Toshihisa Anzai
Elevated left ventricular filling pressure (LVFP) is a powerful indicator of worsening clinical outcomes in heart failure with preserved ejection fraction (HFpEF); however, detection of elevated LVFP is often challenging. This study aimed to determine the association between the newly proposed echocardiographic LVFP parameter, visually assessed time difference between the mitral valve and tricuspid valve opening (VMT) score, and clinical outcomes of HFpEF. We retrospectively investigated 310 well-differentiated HFpEF patients in stable conditions. VMT was scored from 0 to 3 using two-dimensional echocardiographic images, and VMT ≥2 was regarded as a sign of elevated LVFP. The primary endpoint was a composite of cardiac death or heart failure hospitalization during the 2 years after the echocardiographic examination. In all patients, Kaplan–Meier curves showed that VMT ≥2 (n = 54) was associated with worse outcomes than the VMT ≤1 group (n = 256) (P < 0.001). Furthermore, VMT ≥2 was associated with worse outcomes when tested in 100 HFpEF patients with atrial fibrillation (AF) (P = 0.026). In the adjusted model, VMT ≥2 was independently associated with the primary outcome (hazard ratio 2.60, 95% confidence interval 1.46–4.61; P = 0.001). Additionally, VMT scoring provided an incremental prognostic value over clinically relevant variables and diastolic function grading (χ2 10.8–16.3, P = 0.035). In patients with HFpEF, the VMT score was independently and incrementally associated with adverse clinical outcomes. Moreover, it could also predict clinical outcomes in HFpEF patients with AF. Pathophysiology and prognostic impact of VMT scoring in HFpEF patients. Early-diastolic pressure crossover between the left atrial pressure and left ventricular pressure happens earlier with the increase in the LA v wave. In addition, reduced right ventricular (RV) relaxation owing to passive pulmonary hypertension delays early-diastolic pressure crossover between the right atrial pressure and RV pressure. Therefore, early mitral valve opening which precedes tricuspid valve opening pathophysiologically reflects the LAP elevation. HFpEF patients with higher VMT scores were characterized by elevated LAP and subsequent higher RVP, resulting in a higher prevalence of advanced right heart remodelling. As a result, VMT ≥2 was associated with adverse clinical outcomes in HFpEF patients. Notably, VMT ≥2 was also associated with worse outcomes when tested in atrial fibrillation patients. Orange dashed circles indicate the atrioventricular valve which opens earlier in early diastole. Orange vertical lines indicate the timing of pressure crossover between the atrium and ventricle which occurs earlier in early diastole. AF, atrial fibrillation; HF, heart failure; LA, left atrial; LAP, left atrial pressure; LV, left ventricular; LVP, left ventricular pressure; RA, right atrial; RAP, right atrial pressure; RV, right ventricular; RVP, RV pressure; VMT, visually assessed time difference between mitral and tricuspid valves opening.

15 August 2023 in Journal of the American Heart Association
Verified
Journal Article
Open access
KSKimi Sato
Kimi Sato
YSYoshihiro Seo
Yoshihiro Seo
TITomoko Ishizu
Tomoko Ishizu
NANoor K. Albakaa
Noor K. Albakaa
MIMasaki Izumo
Masaki Izumo
MIMasaki Ieda
Masaki Ieda
Background: Prognostic implications of transcatheter aortic valve implantation (TAVI) in low‐gradient (LG) aortic stenosis (AS) remain controversial. The authors hypothesized that differences in cardiac functional recovery may solve this ongoing controversy. The aim was to evaluate clinical outcomes and the response of left ventricular (LV) function following TAVI in patients with LG AS. Methods and Results: This multicenter retrospective study included 1742 patients with severe AS undergoing TAVI between January 2015 and March 2019. Patients were subdivided into low‐flow (LF) LG, normal‐flow (NF) LG, LF high‐gradient, and NF high‐gradient AS groups according to the mean gradient of the aortic valve (LG <40 mm Hg) and LV stroke volume index (LF <35 mL/m 2 ). Outcomes and changes in echocardiographic parameters after TAVI were compared between the groups. A total of 227 patients (13%) had reduced ejection fraction, and 486 patients (28%) had LG AS (LF‐LG 143 [8%]; NF‐LG 343 [20%]). During a median follow‐up period of 747 days, 301 patients experienced a composite end point of cardiovascular death and rehospitalization for cardiovascular events, which was higher in the LF‐LG and NF‐LG groups than in the high‐gradient groups. LG AS was independently associated with the primary outcome (hazard ratio, 1.69; P <0.001). Among 1239 patients with follow‐up echocardiography, LG AS showed less improvement in the LV mass index and LV end‐diastolic volume compared with high‐gradient AS after 1 year, while LV recovery was similar between the LF AS and NF AS groups. Conclusions: LG AS was associated with poorer outcomes and LV recovery, regardless of flow status after TAVI. Careful evaluation of AS severity may be required in LG AS to provide TAVI within the appropriate time and advanced care afterward.